Roche Overview

  • Year Founded
  • 1896

Year Founded

  • Status
  • Public

  • Employees
  • 103,605

Employees

  • Stock Symbol
  • ROG

Stock Symbol

  • Investments
  • 99

  • Share Price
  • $263.55
  • (As of Tuesday Closing)

Roche General Information

Description

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.

Contact Information

Website
www.roche.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Other Industries
Biotechnology
Stock Exchange
SWX
Corporate Office
  • Grenzacherstrasse 124
  • 4070 Basel
  • Switzerland
+41 061 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Roche Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$263.55 $259.99 $254.68 - $323.44 $212B 797M 1.29M $16.02

Roche Financials Summary

In Thousands,
USD
TTM 31-Dec-2023 FY 2023 31-Dec-2023 FY 2022 31-Dec-2022 FY 2021 31-Dec-2021
EV 257,753,180 257,753,180 285,622,959 371,005,264
Revenue 67,237,351 67,237,351 68,927,453 68,692,028
EBITDA 20,407,823 20,407,823 21,777,699 24,348,092
Net Income 12,790,905 12,790,905 13,008,598 15,236,699
Total Assets 107,707,693 107,707,693 95,078,413 100,992,233
Total Debt 36,647,856 36,647,856 28,629,980 35,610,983
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Roche Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Roche‘s full profile, request access.

Request a free trial

Roche Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a vari
Pharmaceuticals
Basel, Switzerland
103,605 As of 2023
000.00
000000000000 000.00

000000

tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
0000000000000
Cambridge, MA
0000 As of 0000
000
000 0000-00-00
000000&0

000000

ip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000 000000000
North Chicago, IL
00000 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Roche Competitors (31)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biogen Formerly VC-backed Cambridge, MA 0000 000 000000&0
AbbVie Corporation North Chicago, IL 00000 000.00 000000000 000.00
Sanofi Corporation Paris, France 00000 00.00 0000 00.00
CSL Corporation Melbourne, Australia 00000 000 000000000 000
Teva Pharmaceutical Industries Corporate Backed or Acquired Petah Tikva, Israel 00000 000.00 000000000 00 000.00
You’re viewing 5 of 31 competitors. Get the full list »

Roche Patents

Roche Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4325206-A1 Method for compensating defective partitions of a microfluidic chip Pending 18-Aug-2022 00000000000 00
EP-4325444-A1 Digital pcr leakage detection and correction methods and systems Pending 18-Aug-2022 000000000 0
US-20240060845-A1 Microfluidic partition leakage detection methods and systems Pending 18-Aug-2022 00000000
US-20240062373-A1 Method for compensation non-valid partitions in dpcr Pending 18-Aug-2022 0000000000
EP-4312028-A1 Sample vessel closure method, movable cap gripper and sample vessel closure system for automatically closing an open end of a sample vessel with a closure cap Pending 29-Jul-2022 G01N35/0099 0
To view Roche’s complete patent history, request access »

Roche Executive Team (72)

Name Title Board Seat Contact Info
Thomas Schinecker Ph.D Chief Executive Officer & Member of Corporate Executive Committee
Matt Sause Chief Executive Officer, Roche Diagnostics & Member of Corporate Executive Committee
Alan Hippe JD Chief Financial & Information Officer & Member of Corporate Executive Committee
Santanu Chattopadhyay MD Chief Operating Officer, West Bengal Cluster
Alexandra Vallon-Eberhard Ph.D Senior Director & Chief Technology Officer, Global Partnering and Strategy Diagnostics
You’re viewing 5 of 72 executive team members. Get the full list »

Roche Board Members (19)

Name Representing Role Since
00000 0000000 00.0 Roche Board Member 000 0000
00000 00000000 Self Vice Chairman, Chairman of Corporate Governance and Sustainability Committee, Chairman of Remuneration Committee and Member of Nomination Committee 000 0000
00000 000000 Self Board Member & Member of Corporate Governance and Sustainability Committee 000 0000
0000000 0000000 Roche Board Member & Member of Remuneration Committee 000 0000
0000000 0000000000 Roche Board Member, Member of Corporate Governance and Sustainability Committee & Member of Audit Committee 000 0000
You’re viewing 5 of 19 board members. Get the full list »

Roche Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Roche Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Roche‘s full profile, request access.

Request a free trial

Roche Investments & Acquisitions (99)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LumiraDx (Point of Care Diagnostics Platform Business) 29-Dec-2023 0000000000 00000 Other Healthcare Technology Systems
Roivant Sciences (Stomach Disease Treatment Drug RVT-3101) 14-Dec-2023 000000000 00.000 Buildings and Property
Telavant 14-Dec-2023 0000000000 00.000 Drug Discovery 0000 0000
Carmot Therapeutics 01-Dec-2023 0000000000 00.00 Biotechnology
MindAhead 01-Jul-2023 Early Stage VC 00000 Application Software
You’re viewing 5 of 99 investments and acquisitions. Get the full list »

Roche Subsidiaries (17)

Company Name Industry Location Founded
Spark Therapeutics Biotechnology Philadelphia, PA 2013
Flatiron Enterprise Systems (Healthcare) New York, NY 0000
MySugr Other Healthcare Services Vienna, Austria 0000
Foundation Medicine Diagnostic Equipment Cambridge, MA 0000
Carmot Therapeutics Biotechnology Berkeley, CA 0000
You’re viewing 5 of 17 subsidiaries. Get the full list »

Roche ESG

Risk Overview

Risk Rating

Updated November, 28, 2023

23.64 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

00.00

Management

Management is related to actions taken to manage ESG issues

00.00

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

00 of 15,605

Rank

00.00

Percentile

Pharmaceuticals

Industry

00 of 870

Rank

00.0

Percentile

Pharmaceuticals

Subindustry

00 of 418

Rank

0.0

Percentile

To view Roche’s complete esg history, request access »

Roche Exits (20)

Company Name Exit Date Exit Type Exit Size Status Buyers
TIB Molbiol Syntheselabor 01-Dec-2021 000000000000000000 00000 Completed
  • 00000
Ariosa Diagnostics 12-Jan-2015 000000000000000000 00000 Completed
  • 00000
Allakos 24-Sep-2014 00000 00000 00 0000 Completed
  • 9 buyers
Kytril 18-Jun-2014 000000000 00000 00 00.000 Completed
  • 00000
ProMining Therapeutics 17-Dec-2012 Corporate Completed
You’re viewing 5 of 20 exits. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »